Lithuanian CVD Implementation Guide
0.0.1 - ci-build
Lithuanian CVD Implementation Guide
0.0.1 - ci-build
Lithuanian CVD Implementation Guide, published by Lithuanian Medical Library. This guide is not an authorized publication; it is the continuous build for version 0.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7LT/ig-lt-cvd/ and changes regularly. See the Directory of published versions
| Official URL: https://hl7.lt/fhir/cvd/ImplementationGuide/lt.hl7.fhir.cvd | Version: 0.0.1 | ||||
| Computable Name: LTCvd | |||||
This Implementation Guide specifies how to consistently represent and exchange structured clinical data for the Lithuanian cardiovascular disease (CVD) prevention and early diagnosis programme using the HL7® FHIR® R5 standard.
It supports national ESPBI electronic forms and workflows for the patient CVD risk assessment questionnaire and the CVD prevention measures plan (including follow-up achievement evaluation). The guide enables:
A concise clinical pathway from primary assessment through follow-up is described on the Workflow page.
Standardised FHIR resources allow consistent reporting to programme administrators, coordination between primary care and specialists, and alignment with national questionnaire and prevention-plan datasets. Implementers can validate payloads against published profiles and value sets, reducing ambiguity in integrations and registries.
The profiles support structured documentation of cardiovascular risk (numeric estimate and category), heart and vessel disease risk group for programme eligibility and recall, comorbidities that affect CVD risk, modifiable and non-modifiable risk factors, ECG when used in assessment, and individualised prevention plans (e.g. LDL and blood pressure targets, smoking cessation, nutrition, physical activity, weight, and prescribed medication context). Data can be reused at follow-up visits for achievement review.
This IG defines the following artefacts. Each name links to its definition in this publication.
| Need in programme forms | Profile / extension |
|---|---|
| SCORE2-style CVD risk (%) and qualitative risk degree | CVDRiskAssessmentLtCvd |
| Programme risk group for heart and vessel diseases | RiskGroupObservationLtCvd |
| Risk group on CarePlan (extension) | RiskGroupExtLtCvd |
| Accompanying chronic diseases (CVD programme list) | CvdChronicConditionLtCvd |
| Risk factors (structured status / count) | RiskFactorStatusLtCvd |
| CVD prevention and screening care plan | CarePlanLtCvd |
| ECG finding in assessment context | EKGLtCvd |
Terminology (value sets and code systems used by these profiles) is published under this guide and tx.hl7.lt; see the Artifacts index.
Demographics, practitioner, organisation, and encounter patterns use LT Base profiles where applicable. Vital signs (e.g. blood pressure, weight, height, BMI), laboratory results (lipids, glucose, HbA1c), and lifestyle observations (smoking, alcohol, physical activity, diet) are modelled in LT VitalSigns, LT Lab, and LT Lifestyle respectively. This CVD IG focuses on programme-specific risk stratification, conditions, risk factors, plans, and ECG—not on redefining those base measurements.
See Workflow for the end-to-end pathway. Use Artifacts for the full list of profiles, extensions, terminology, and examples.
| Name | Role | Organization |
|---|---|---|
| Kati Laidus | Co-Author | HELEX Solutions |
| Igor Bossenko | Co-Author | HELEX Solutions |
| Martynas Bieliauskas | Co-Author | LMB |
| Audra Stepanauskaite | Co-Author | LMB |
| Albert Kušlevič | Co-Author | LMB |